Vivos (RDGL) Cash from Financing Activities (2010 - 2025)

Vivos (RDGL) reported Cash from Financing Activities of -$845.0 for Q4 2025, down 100.06% on a YoY basis from $1.5 million in Q4 2024, and down 100.06% sequentially from $1.5 million in Q1 2025.

Vivos (RDGL) Cash from Financing Activities (2010 - 2025) Analysis & Trends

Vivos (RDGL) has 15 years of Cash from Financing Activities data on file, last reported at -$845.0 in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 100.06% year-over-year to -$845.0; the trailing twelve-month figure through Dec 2025 stood at $1.5 million (down 34.6% YoY), and the FY2025 full-year result was $1.5 million, down 34.6% from the prior year.
  • Cash from Financing Activities slipped to -$845.0 in Q4 2025, from $1.5 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $1.8 million in Q1 2021 to a low of -$145000.0 in Q4 2021.
  • A 4-year average of $667335.9 and a median of $518580.0 in 2023 frame the typical range for Cash from Financing Activities.
  • Peak annual rise in Cash from Financing Activities reached 2420.16% in 2021, while the deepest fall reached 111.56% in 2021.
  • Tracing RDGL's Cash from Financing Activities over 4 years: stood at -$145000.0 in 2021, then jumped by 457.64% to $518580.0 in 2023, then soared by 182.56% to $1.5 million in 2024, then slumped by 100.06% to -$845.0 in 2025.
  • Business Quant data shows RDGL's Cash from Financing Activities at -$845.0 in Q4 2025, $1.5 million in Q1 2025, and $1.5 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 183.03 Bn 175.74 Bn 6.27 Bn 17.31 Bn
2 Stryker 129.38 Bn 126.50 Bn 3.81 Bn -1.51 Bn
3 Medtronic 108.86 Bn 99.64 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 68.57 Bn 67.12 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 47.66 Bn 43.99 Bn 1.29 Bn -451.20 Mn
6 Dexcom 28.64 Bn 27.52 Bn 750.30 Mn -25.00 Mn
7 GE HealthCare Technologies 28.55 Bn 26.27 Bn 1.98 Bn 21.00 Mn
8 Smith & Nephew 27.02 Bn 26.44 Bn - -
9 Koninklijke Philips 25.54 Bn 22.42 Bn 2.07 Bn -26.93 Mn
10 Vivos 27.57 Mn 26.01 Mn -3,105.00 -845.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -845.00
Dec 31, 2025 -845.00
Mar 31, 2025 1.51 Mn
Mar 31, 2025 1.51 Mn
Dec 31, 2024 1.47 Mn
Dec 31, 2024 1.47 Mn
Jun 30, 2024 709,000.00
Jun 30, 2024 709,000.00
Mar 31, 2024 130,000.00
Mar 31, 2024 130,000.00
Dec 31, 2023 518,580.00
Dec 31, 2023 518,580.00
Sep 30, 2023 10,000.00
Sep 30, 2023 10,000.00
Dec 31, 2021 -145,000.00
Dec 31, 2021 -145,000.00
Mar 31, 2021 1.81 Mn
Mar 31, 2021 1.81 Mn
Dec 31, 2020 1.25 Mn
Dec 31, 2020 1.25 Mn